Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass

OBJECTIVES: Noggin inactivates bone morphogenetic proteins (BMPs), possibly exerting negative effects on the skeleton. We aimed to compare the effect of agents with opposite impact on bone turnover on noggin circulating levels. METHODS: In this observational, open label, non-randomized clinical stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Anastasilakis, Athanasios D., Polyzos, Stergios A., Makras, Polyzois, Rauner, Martina, Sonnleitner, Linda, Hawa, Gerhard, Tsourdi, Elena, Yavropoulou, Maria P., Missbichler, Albert, Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Musculoskeletal and Neuronal Interactions 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737552/
https://www.ncbi.nlm.nih.gov/pubmed/31475931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737552/
https://www.ncbi.nlm.nih.gov/pubmed/31475931

Ejemplares similares